PT101461B - NUTRIENT LIQUID FOR NEWBORN - Google Patents
NUTRIENT LIQUID FOR NEWBORN Download PDFInfo
- Publication number
- PT101461B PT101461B PT10146194A PT10146194A PT101461B PT 101461 B PT101461 B PT 101461B PT 10146194 A PT10146194 A PT 10146194A PT 10146194 A PT10146194 A PT 10146194A PT 101461 B PT101461 B PT 101461B
- Authority
- PT
- Portugal
- Prior art keywords
- liquid nutrient
- mmol
- sodium
- electrolytes
- potassium
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
A presente invenção refere-se a um nutriente líquido para recém-nascidos de acordo com a introdução da reivindicação 1.The present invention relates to a liquid nutrient for newborns according to the introduction of claim 1.
É já conhecido um nutriente líquido desta natureza da Descrição DE-PS 2 457 733.A liquid nutrient of this nature is already known from Description DE-PS 2 457 733.
Com este nutriente líquido é possível fornecer oralmente aos recém-nascidos e aos prematuros energia em quantidade suficiente, podendo ser administrado líquido suficiente devido à relativamente reduzida osmolaridade, de modo que não ocorra a chamada febre da sede.With this liquid nutrient, it is possible to supply newborns and premature babies with sufficient energy orally, and sufficient liquid can be administered due to the relatively low osmolarity, so that the so-called thirst fever does not occur.
Na realidade os nutrientes líquidos conhecidos estão associados ao risco de provocarem uma intoxicação hídrica se for administrado demasiado líquido num período de tempo curto.In fact, the known liquid nutrients are associated with the risk of causing water poisoning if too much liquid is administered in a short period of time.
Como consequência deste estado de perigo de vida surgem vómitos, edemas pulmonares, dispneia, reduzida secreção de urina, bem como perturbações da função cardíaca.As a consequence of this life-threatening state, vomiting, pulmonary edema, dyspnoea, reduced urine secretion, and disturbances in cardiac function arise.
A invenção resulta pois da necessidade de se pôr à disposição um nutriente líquido do tipo descrito que não cause intoxicação hídrica, mesmo para doses elevadas.The invention therefore results from the need to provide a liquid nutrient of the type described that does not cause water intoxication, even at high doses.
Este problema é solucionado de acordo com a invenção adicionando-se ao nutriente líquido electrólitos na forma de sódio, potássio e cloreto.This problem is solved according to the invention by adding electrolytes to the liquid nutrient in the form of sodium, potassium and chloride.
Através da adição destes electrólitos impede-se uma intoxicação hídrica, fornecendo-se apesar disso ao recémnascido energia em quantidade suficiente.By adding these electrolytes, water intoxication is prevented, yet the newborn is supplied with sufficient energy.
notável aperfeiçoamento dos nutrientes líquidos conduz também a que não ocorra uma hiponatriémia, como acontece em recém-nascidos que foram alimentados apenas com maltodextrina e nos quais o nível do sódio no sangue é demasiado baixo.a remarkable improvement in liquid nutrients also leads to hyponatraemia not occurring, as in newborns who were fed only maltodextrin and in which the level of sodium in the blood is too low.
A adição de electrólitos, que de resto também estão presentes no sangue do cordão umbilical e no colostro, deverá fazer-se, de harmonia com uma variante de realização vantajosaThe addition of electrolytes, which are also present in the umbilical cord blood and colostrum, should be done, in harmony with a variant of advantageous realization
-1 da invenção, numa gama de 20 a 40 mmol/1 de sódio, 5 a 20 mmol/1 de potássio e 20 a 60 mmol/1 de cloreto. Adiciona-se ao nutriente líquido de preferência uma proporção de 30 mmol/1 de í-1 of the invention, in a range of 20 to 40 mmol / 1 of sodium, 5 to 20 mmol / 1 of potassium and 20 to 60 mmol / 1 of chloride. Preferably, a ratio of 30 mmol / 1 μl is added to the liquid nutrient.
sódio, 10 mmol/1 de potássio e 40 mmol/1 de cloreto. A osmolaridade situa-se neste caso em cerca de 200 mosmol/í.sodium, 10 mmol / 1 potassium and 40 mmol / 1 chloride. In this case, osmolarity is about 200 mosmol / µ.
Lisboa, 14 de Fevereiro de 1994 0 AGEITE OFICIAL DA PBOPEIEDADE LXDfSIEIALLisbon, February 14, 1994 0 OFFICIAL AGEITE OF PBOPEIEDADE LXDfSIEIAL
-21. Nutriente líquido para recém-nascidos com uma proporção de a 45% em peso de maltodextrina, no qual a osmolaridade total do nutriente líquido não ultrapassa 350 mosmol/1, caracterizado por se adicionarem electrólitos na forma de sódio, potássio e cloreto.-21. Liquid nutrient for newborns with a proportion of 45% by weight of maltodextrin, in which the total osmolarity of the liquid nutrient does not exceed 350 mosmol / 1, characterized by the addition of electrolytes in the form of sodium, potassium and chloride.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PT10146194A PT101461B (en) | 1994-02-14 | 1994-02-14 | NUTRIENT LIQUID FOR NEWBORN |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PT10146194A PT101461B (en) | 1994-02-14 | 1994-02-14 | NUTRIENT LIQUID FOR NEWBORN |
Publications (2)
Publication Number | Publication Date |
---|---|
PT101461A PT101461A (en) | 1995-09-12 |
PT101461B true PT101461B (en) | 1997-06-30 |
Family
ID=20085366
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT10146194A PT101461B (en) | 1994-02-14 | 1994-02-14 | NUTRIENT LIQUID FOR NEWBORN |
Country Status (1)
Country | Link |
---|---|
PT (1) | PT101461B (en) |
-
1994
- 1994-02-14 PT PT10146194A patent/PT101461B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PT101461A (en) | 1995-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Feuvray et al. | Effects of ischemia on rat myocardial function and metabolism in diabetes. | |
Kassirer et al. | Correction of metabolic alkalosis in man without repair of potassium deficiency: A re-evaluation of the role of potassium | |
Anwer et al. | Hepatotoxic bile acids increase cytosolic Ca++ activity of isolated rat hepatocytes | |
Tidball | Magnesium and calcium as regulators of intestinal permeability | |
Berthelot et al. | Effects of dietary magnesium on the development of hypertension in the spontaneously hypertensive rat. | |
PT101461B (en) | NUTRIENT LIQUID FOR NEWBORN | |
Krawitt et al. | Calcium absorption and brush border phosphatases following dietary calcium restriction | |
Bourre et al. | Alteration of 5′‐Nucleotidase and Na+, K+‐ATPase in Central and Peripheral Nervous Tissue from Dysmyelinating Mutants (jimpy, quaking, Trembler, shiverer, and mld). Comparison with CNPase in the Developing Sciatic Nerve from Trembler | |
GB2015050A (en) | Bleach Activator Granules | |
Coburn et al. | Calcium, Phosphorus and Citrate Interactions in Oxalate Urolithiasis Produced with α Low-Phosphorus Diet in Rats | |
Kleinman et al. | Renal response of the new-born dog to a saline load: the role of intrarenal blood flow distribution | |
Okuda et al. | Effects of ethylenediaminetetraacetate and metal ions in intestinal absorption of vitamin B12 in man and rats | |
Goglia et al. | The effect of thyroid state on respiratory activities of three rat liver mitochondrial fractions | |
Armbrecht | Age and the effects of lactose on calcium and phosphorus uptake by rat small intestine | |
GB520753A (en) | Improvements in photographic developers | |
Rigault et al. | Respiration and oxidative phosphorylation by mitochondria of red and white skeletal muscle | |
Johnson et al. | The effect of subtotal parathyroidectomy and renal transplantation on mineral balance and secondary hyperparathyroidism in chronic renal failure | |
LASSILA et al. | Impact of streptozotocin‐induced diabetes on rat blood and alveolar bone affected by occlusal stress | |
Kelada et al. | Health effects of long-term exposure to sodium sulfate dust | |
Tomoda et al. | Primary changes in liver damage by aspirin in rats | |
Moorthy et al. | Synthesis of glycogen from glucose and lactate in isolated rat soleus muscle | |
Richter et al. | High-affinity glutamine uptake of the rat hippocampus during postnatal development: a quantitative autoradiographic study | |
Villamil et al. | Changes in vascular ionic content and distribution across aortic coarctation in the dog | |
Dhalla et al. | Calcium transport by the subcellular particles of the skeletal muscle of genetically dystrophic hamster | |
Flaxman | The Course of Hypertensive Heart Disease: I. Age of Onset, Development of Cardiac Insufficiency, Duration of Life, and Cause of Death |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG3A | Patent granted, date of granting |
Effective date: 19970319 |
|
MM3A | Annulment or lapse |
Effective date: 20050816 |